LCLN Stock Analysis: Lincoln International | NYSE
Capital Markets | NYSE, USA | Market Cap: 2.730m USD | 12M Return: 16.7% | US5337141015 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 9.37M
Rev. Trend: 96.6%
Warnings
No concerns identified
Tailwinds
Seasonality 0.2 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Lincoln International, Inc. (LCLN) is an independent investment banking advisory firm focused on private capital markets, operating in the United States and internationally. Founded in 1996 and headquartered in Chicago, Illinois, the company conducts business through two main segments: Investment Banking Advisory, which covers capital advisory services (debt advisory, special situations and restructuring, and growth/minority equity) and private funds advisory (structured/continuation vehicles, single asset vehicles, primary funds, and co-investment vehicles); and Valuations and Opinions, which provides portfolio valuations, transaction opinions, board advisory, and disputes advisory services to alternative asset managers and institutional investors. The firm also offers strategic consulting, an executive peer exchange program called Connect, and an agency member network known as FirstChoice, serving clients across the Business Services, Consumer, Healthcare, Industrials, and Technology sectors.
As a fee-based advisory firm, Lincoln International generates revenue primarily through transaction fees, retainer fees, and valuation engagements rather than by taking principal investment positions, a common business model within the capital markets industry. The companys focus on private capital markets and middle-market advisory distinguishes it from large bulge-bracket banks that typically serve larger public-company transactions.
- Private market M&A deal volumes drive advisory segment revenue
- Valuations and Opinions expands with private credit fund mandates
- IPO proceeds fund advisor hiring and platform investment
| Net Income: -21.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.10 > 0.02 and ΔFCF/TA -11.88 > 1.0 |
| NWC/Revenue: 54.39% < 20% (prev 60.01%; Δ -5.62% < -1%) |
| CFO/TA 0.10 > 3% & CFO 103.3m > Net Income -21.0m |
| Net Debt (302.1m) to EBITDA (19.0m): 15.86 < 3 |
| Current Ratio: 2.41 > 1.5 & < 3 |
| Outstanding Shares: last fiscal year (102.0m) vs prev -1.57% < -2% |
| Gross Margin: 36.93% > 18% (prev 69.81%; Δ -32.89% > 0.5%) |
| Asset Turnover: 46.83% > 50% (prev 90.41%; Δ -43.58% > 0%) |
| Interest Coverage Ratio: error (cannot be calculated; needs correct EBIT TTM and Interest Expense TTM) |
| A: 0.21 (Total Current Assets 356.4m - Total Current Liabilities 147.9m) / Total Assets 997.8m |
| B: 0.00 (Retained Earnings 455k / Total Assets 997.8m) |
| C: -0.02 (EBIT TTM -19.4m / Avg Total Assets 819.0m) |
| D: 0.32 (Book Value of Equity 179.5m / Total Liabilities 560.5m) |
| Altman-Z'' = 1.55 = BB |
| DSRI: 1.16 (Receivables 105.8m/138.2m, Revenue 383.5m/578.7m) |
| GMI: 1.89 (GM 69.81% / 36.93%) |
| AQI: 3.09 (AQ_t 0.48 / AQ_t-1 0.15) |
| SGI: 0.66 (Revenue 383.5m / 578.7m) |
| TATA: -0.12 (NI -21.0m - CFO 103.3m) / TA 997.8m) |
| Beneish M = -1.11 (Cap -4..+1) = D |
As of September 05, 2026, the stock is trading at USD 27.19 with a total of 621,891 shares traded. Over the past week, the price has changed by +7.36%, over one month by +31.63%, over three months by +15.27% and over the past year by +16.72%.
Current recommended Stop Loss: 24.50 (which is 9.9% or 2.3 ATR below the current price).
Lincoln International has no consensus analysts rating.
P/S = 3.1248
P/B = 6.4356
Revenue TTM = 383.5m USD
EBIT TTM = -19.4m USD
EBITDA TTM = 19.0m USD
Long Term Debt = 270.4m USD (from longTermDebt, last fiscal year)
Short Term Debt = 139.9m USD (from shortTermDebt, last quarter)
Debt = 552.7m USD (corrected: LT Debt 270.4m + ST Debt 139.9m) + Leases 142.5m
Net Debt = 302.1m USD (calculated: Debt 552.7m - CCE 250.6m)
Enterprise Value = 3.03b USD (2.73b + Debt 552.7m - CCE 250.6m)
Interest Coverage Ratio = unknown (Ebit TTM -19.4m / Interest Expense TTM 0.0)
EV/FCF = 30.08x (Enterprise Value 3.03b / FCF TTM 100.8m)
FCF Yield = 3.32% (FCF TTM 100.8m / Enterprise Value 3.03b)
FCF Margin = 26.29% (FCF TTM 100.8m / Revenue TTM 383.5m)
Net Margin = -5.48% (Net Income TTM -21.0m / Revenue TTM 383.5m)
Gross Margin = 36.93% ((Revenue TTM 383.5m - Cost of Revenue TTM 241.9m) / Revenue TTM)
Gross Margin QoQ = 13.22% (prev 70.83%)
Tobins Q-Ratio = 3.04 (Enterprise Value 3.03b / Total Assets 997.8m)
Interest Expense / Debt = 0.0% (Interest Expense 0.0 / Debt 552.7m)
Taxrate = 2.60% (5.72m / 219.9m)
NOPAT = -18.9m (EBIT -19.4m * (1 - 2.60%)) [loss with tax shield]
Current Ratio = 2.41 (Total Current Assets 356.4m / Total Current Liabilities 147.9m)
Debt / Equity = 3.08 (Debt 552.7m / totalStockholderEquity, last quarter 179.5m)
Debt / EBITDA = 15.86 (Net Debt 302.1m / EBITDA 19.0m)
Debt / FCF = 3.00 (Net Debt 302.1m / FCF TTM 100.8m)
Total Stockholder Equity = 431.2m (last fiscal year from totalStockholderEquity)
RoA = -2.57% (Net Income -21.0m / Total Assets 997.8m)
RoE = -4.88% (Net Income TTM -21.0m / Total Stockholder Equity 431.2m)
RoCE = -2.77% (EBIT -19.4m / Capital Employed (Equity 431.2m + L.T.Debt 270.4m))
RoIC = -1.95% (negative operating profit) (NOPAT -18.9m / Invested Capital 970.6m)
WACC = 4.66% (E(2.73b)/V(3.28b) * Re(5.60%) + D(552.7m)/V(3.28b) * Rd(0.0%) * (1-Tc(0.03)))
Discount Rate = 5.60% (= CAPM, Blume Beta Adj.)
Shares (yearly) Correlation: 33.33 | Cagr: 286.1%
[DCF] Terminal Value 73.10% ; FCFF base≈116.8m ; Y1≈102.4m ; Y5≈82.7m
[DCF] Fair Price = 29.44 (EV 1.33b - Net Debt 302.1m = Equity 1.03b / Shares 34.8m; r=8.35% [WACC [floored]]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: N/A | # QB: 0
Revenue Correlation: 96.55 | Revenue CAGR: 22.97% | SUE: N/A | # QB: 0
EPS current Quarter (2026-09-30): EPS=0.27 | Chg30d=+1.16% | Revisions=+17% | Analysts=7
EPS current Year (2026-12-31): EPS=1.36 | Chg30d=+11.24% | Revisions=+62% | GrowthEPS=+0.0% | GrowthRev=+29.8%
EPS next Year (2027-12-31): EPS=1.74 | Chg30d=+1.50% | Revisions=+12% | GrowthEPS=+28.0% | GrowthRev=+14.3%
[Analyst] Revisions Ratio: +44% (up=10, down=3)